Plerixafor
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Plerixafor?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Plerixafor, sold under the brand name Mozobil, is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Mozobil |
Other names | JM 3100, AMD3100 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a609018 |
License data |
|
Pregnancy category |
|
Routes of administration | Subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | Up to 58% |
Metabolism | None |
Elimination half-life | 3–5 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H54N8 |
Molar mass | 502.796 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close